Product Description

NOBIVAC® INTRA-TRAC®3 has been shown to be effective for vaccination of healthy dogs 3 weeks of age or older against canine adenovirus type 2, canine parainfluenza virus and Bordetella bronchiseptica. NOBIVAC® INTRA-TRAC®3 PROVIDES PROTECTION AGAINST TRACHEOBRONCHITIS (“CANINE COUGH”). Canine Adenovirus 2, Canine Parainfluenza Virus (modified live viruses), Bordetella Bronchiseptica (avirulent live culture).
-Protects against Bordetella, canine parainfluenza virus, and canine adenovirus type
-Offers the superior benefits of intranasal administration
-Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response
-Requires only single-nostril administration—low dose of 0.5 mL
-Provides rapid protection beginning as early as 48 hours post-vaccination against B. bronchiseptica14
-Proven 1-year duration of immunity for B. bronchiseptica15

CAUTION
1. THIS PRODUCT IS DESIGNED FOR INTRANASAL USE ONLY WITH THE ENCLOSED APPLICATORS. Systemic reactions resulting from inadvertent intramuscular or subcutaneous injection have been reported. Symptoms may include vomiting, diarrhea, lethargy, inappetence, jaundice and death associated with liver failure. Localized tissue necrosis at the injection site has also been reported. If inadvertent injection occurs, monitor the dog closely. Supportive therapy including IV fluids and treatment with gentamicin, tetracycline, trimethoprim/sulfa, or amoxicillin/clavulanic acid may be indicated. If anaphylactoid reaction occurs, use epinephrine.
2. Post vaccinal reactions consisting of mild canine cough syndrome may occur following use of this vaccine.
3. For animal use only. Store at 2° - 8°C (35° - 46°F). Do not freeze. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant bitches. Inactivate unused contents before disposal. In case of human exposure, contact a physician.
4. This vaccine contains penicillin, streptomycin and nystatin as preservatives.